ArticleExpert opinion on orphan drugs2020

The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism.

Whitney S Thompson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.